EU meeting
This article was originally published in The Rose Sheet
Executive Summary
European Partnership to Promote Alternative Approaches to Animal Testing (EPAA) will present its draft action plan during European Commission Health & Consumer Protection DG Inter-Committee Coordination Group meeting April 5, according to 1agenda posted to EC's Web site. EPAA was founded in November by industry and government reps to explore ways to reduce animal use; group intends to undertake projects such as evaluating new in vitro tests, current test method quality and intelligent chemical testing strategies (2"The Rose Sheet" Nov. 14, 2005, p. 8). Coordination group, comprising Scientific Committee on Consumer Products, Scientific Committee on Emerging and Newly-Identified Health Risks and Scientific Committee on Health and Environmental Risks, also will discuss new requests to each committee and their positions on alternative testing methods...
You may also be interested in...
European Partnership Aims To Facilitate Animal Alternatives
A European Commission task force will develop an action program with "concrete activities" in early 2006 to help identify barriers to progress and solutions to promote the acceptance and validation of animal alternative tests, the commission said
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.